Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01487499 · ClinicalTrials.gov registry record · Phase 3
Bronchoscopic Intratumoral Chemotherapy for Small Cell Lung Cancer (SCLC)
A Phase 3 study, sponsored by University of Florida.
- Terminated
- Registry status
- Phase 3
- Development phase
- 4
- Enrollment target
NCT01487499 is a Phase 3 study that was terminated before completion, run by University of Florida. The registered enrollment target is 4 participants.
The verdict
NCT01487499, a Phase 3 study, was terminated before completion, sponsored by University of Florida.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 4 participants
- Enrollment target
Study Summary
This project proposes to use bronchoscopic intratumoral chemotherapy for small cell lung cancer in two fashions: 1. to implement a prospective clinical trial to test the feasibility and efficacy of intralesional chemotherapy as consolidative therapy immediately following standard systemic chemotherapy and radiation therapy for patients with limited stage SCLC by comparing tumor growth and survival rates of the treatment group and compare the outcomes to historical controls 2. to implement a prospective clinical trial to test the feasibility and efficacy as measured by tumor growth and survival rates of intralesional chemotherapy for patients with recurrent SCLC after standard treatment.
Interventions
- DRUG Cisplatin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2011-12 |
| Est. Completion | 2015-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01487499
The ClinicalTrials.gov registry entry for NCT01487499 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cisplatin is the first listed.
NCT01487499 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01487499 about?
NCT01487499 is a clinical study titled "Bronchoscopic Intratumoral Chemotherapy for Small Cell Lung Cancer (SCLC)". This project proposes to use bronchoscopic intratumoral chemotherapy for small cell lung cancer in two fashions: 1. to implement a prospective clinical trial to test the feasibility and efficacy of intralesional chemotherapy as consolidative therapy immediately following standard systemic chemother...
What is the current status of trial NCT01487499?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 4 participants. The study started on 2011-12. Estimated completion is 2015-03.
What interventions are being tested in trial NCT01487499?
The interventions under investigation include: Cisplatin (DRUG).
Who is sponsoring clinical trial NCT01487499?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.